Literature DB >> 11906150

Continuous spectrometric assays for glutaminyl cyclase activity.

Stephan Schilling1, Torsten Hoffmann, Michael Wermann, Ulrich Heiser, Claus Wasternack, Hans-Ulrich Demuth.   

Abstract

The enzymatic conversion of one chromogenic substrate, l-glutamine-p-nitroanilide, and two fluorogenic substrates, l-glutaminyl-2-naphthylamide and l-glutaminyl-4-methylcoumarinylamide, into their respective pyroglutamic acid derivatives by glutaminyl cyclase (QC) was estimated by introducing a new coupled assay using pyroglutamyl aminopeptidase as the auxiliary enzyme. For the purified papaya QC, the kinetic parameters were found to be in the range of those previously reported for other glutaminyl peptides, such as Gln-Gln, Gln-Ala, or Gln-tert-butyl ester. The assay can be performed in the presence of ammonia up to a concentration of 50 mM. Increasing ionic strength, e.g., potassium chloride up to 300 mM, resulted in an increase in enzymatic activity of about 20%. This is the first report of a fast, continuous, and reliable determination of QC activity, even in the presence of ammonium ions, during the course of protein purification and enzymatic analysis. (c)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906150     DOI: 10.1006/abio.2001.5560

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  13 in total

1.  Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening.

Authors:  Mária Szaszkó; István Hajdú; Beáta Flachner; Krisztina Dobi; Csaba Magyar; István Simon; Zsolt Lőrincz; Zoltán Kapui; Tamás Pázmány; Sándor Cseh; György Dormán
Journal:  Mol Divers       Date:  2017-01-09       Impact factor: 2.943

2.  Biodegradable poly(ethylene glycol) hydrogels based on a self-elimination degradation mechanism.

Authors:  Manjeet Deshmukh; Yashveer Singh; Simi Gunaseelan; Dayuan Gao; Stanley Stein; Patrick J Sinko
Journal:  Biomaterials       Date:  2010-06-19       Impact factor: 12.479

3.  Molecular characterization of tick salivary gland glutaminyl cyclase.

Authors:  Steven W Adamson; Rebecca E Browning; Chien-Chung Chao; Robert C Bateman; Wei-Mei Ching; Shahid Karim
Journal:  Insect Biochem Mol Biol       Date:  2013-06-13       Impact factor: 4.714

4.  Pyroglutamate-amyloid-β and glutaminyl cyclase are colocalized with amyloid-β in secretory vesicles and undergo activity-dependent, regulated secretion.

Authors:  Holger Cynis; Lydiane Funkelstein; Thomas Toneff; Charles Mosier; Michael Ziegler; Birgit Koch; Hans-Ulrich Demuth; Vivian Hook
Journal:  Neurodegener Dis       Date:  2014-06-18       Impact factor: 2.977

5.  siRNA screen identifies QPCT as a druggable target for Huntington's disease.

Authors:  Michael Hannus; Birte Sönnichsen; Sara Imarisio; Angeleen Fleming; Maria Jimenez-Sanchez; Wun Lam; Alessia Tarditi; Fiona Menzies; Teresa Ed Dami; Catherine Xu; Eduardo Gonzalez-Couto; Giulia Lazzeroni; Freddy Heitz; Daniela Diamanti; Luisa Massai; Venkata P Satagopam; Guido Marconi; Chiara Caramelli; Arianna Nencini; Matteo Andreini; Gian Luca Sardone; Nicola P Caradonna; Valentina Porcari; Carla Scali; Reinhard Schneider; Giuseppe Pollio; Cahir J O'Kane; Andrea Caricasole; David C Rubinsztein
Journal:  Nat Chem Biol       Date:  2015-04-06       Impact factor: 15.040

6.  Natural Products from Microalgae with Potential against Alzheimer's Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors.

Authors:  Stephanie Hielscher-Michael; Carola Griehl; Mirko Buchholz; Hans-Ulrich Demuth; Norbert Arnold; Ludger A Wessjohann
Journal:  Mar Drugs       Date:  2016-11-02       Impact factor: 5.118

7.  Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients.

Authors:  Claire Bridel; Torsten Hoffmann; Antje Meyer; Sisi Durieux; Marleen A Koel-Simmelink; Matthias Orth; Philip Scheltens; Inge Lues; Charlotte E Teunissen
Journal:  Alzheimers Res Ther       Date:  2017-06-06       Impact factor: 6.982

8.  A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects.

Authors:  Inge Lues; Frank Weber; Antje Meyer; Uli Bühring; Torsten Hoffmann; Kerstin Kühn-Wache; Susanne Manhart; Ulrich Heiser; Rolf Pokorny; Joseph Chiesa; Konrad Glund
Journal:  Alzheimers Dement (N Y)       Date:  2015-10-03

9.  DMTMM-Mediated Intramolecular Cyclization of Acidic Residues in Peptides/Proteins.

Authors:  Chi-Hua Lee; Yuan-Chao Lou; Andrew H-J Wang
Journal:  ACS Omega       Date:  2021-02-05

10.  Soluble variants of human recombinant glutaminyl cyclase.

Authors:  Cristiana Castaldo; Silvia Ciambellotti; Raquel de Pablo-Latorre; Daniela Lalli; Valentina Porcari; Paola Turano
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.